Maureen Graham has approximately 30 years’ experience within the pharmaceutical industry, largely within the field of Regulatory Affairs.
A Pharmacist by training, she started her career as a Regulatory Affairs Officer with Glaxo Group Research, progressing through various companies and opportunities including Regulatory Manager at Merck Sharp and Dohme, European Director of Regulatory Affairs at Ivax, then Amgen and finally Niche Generics Limited. In October 2005, Maureen started Diamond BioPharm Limited, a Regulatory Affairs consultancy company, which expanded to cover pharmacovigilance activities through Diamond PV Services Limited.
Maureen has direct experience of many fields of activity including biotechnology, gene-therapy, new chemical entities and generics. Maureen also has extensive experience and knowledge of all European regulatory procedures (national, mutual recognition, decentralised and centralised). Maureen has assisted a wide range of pharmaceutical companies (small, medium and large) from early stages of product development through to marketing authorisation approvals. She has broad experience across key areas of regulatory activity (chemical and pharmaceutical, non-clinical and clinical), and also advises on Regulatory strategies and requirements.